Beta Glucan Market Outlook
Global Beta Glucan Market Growth, Size, Trends Analysis- By Product, By Application, By Source – Regional Outlook, Competitive Strategies and Segment Forecast to 2035
| Published: Jun-2026 | Report ID: FOOD2605 | Pages: 1 - 250 | Formats*: |
| Category : Food & Beverages | |||
- In July 2023, BENEO introduced Orafti β-Fit, its first barley beta-glucan ingredient designed to support heart health and blood sugar management. The launch strengthened the company’s presence in the global fiber and cardio-metabolic health markets while expanding its product portfolio.
- In November 2022, Ceapro Inc. advanced the expansion of its proprietary Pressurized Gas eXpanded (PGX) technology to support the development of pharmaceutical and nutraceutical products. As part of this initiative, alginate and yeast beta-glucan were selected as the first bioactive ingredients for processing, strengthening the company’s innovation capabilities and expanding its product portfolio.
| Report Metric | Details |
|---|---|
| Market size available for years | 2022-2035 |
| Base year considered | 2025 |
| Forecast period | 2026-2035 |
| Segments covered | By Product, By Application, By Source |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Biotec Pharmacon ASA, Biothera Pharmaceuticals, Cargill Incorporated, Ceapro Inc., DSM NV, Frutarom, Garuda International, Inc., GlycaNova AS, Groupe Soufflet SA (AIT Ingredients), Immunomedics, Lesaffre Human Care, Millipore Sigma, Super Beta Glucan Inc., Tate & Lyle Plc (Tate & Lyle Oat Ingredients), and Zilor Inc. (Biorigin). |
- Global Beta Glucan Market Size (FY’2022-FY’2035)
- Overview of Global Beta Glucan Market
- Segmentation of Global Beta Glucan Market by Product (Soluble, Insoluble)
- Segmentation of Global Beta Glucan Market by Application (Food & Beverage, Cosmetics & Personal Care, Pharmaceuticals, Animal Feed, Other Applications)
- Segmentation of Global Beta Glucan Market by Source (Cereal, Mushroom, Yeast, Seaweed)
- Statistical Snap of Global Beta Glucan Market
- Expansion Analysis of Global Beta Glucan Market
- Problems and Obstacles in Global Beta Glucan Market
- Competitive Landscape in the Global Beta Glucan Market
- Details on Current Investment in Global Beta Glucan Market
- Competitive Analysis of Global Beta Glucan Market
- Prominent Players in the Global Beta Glucan Market
- SWOT Analysis of Global Beta Glucan Market
- Global Beta Glucan Market Future Outlook and Projections (FY’2026-FY’2035)
- Recommendations from Analyst
1.1. Scope of the report1.2. Market segment analysis
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6.1. Global Beta Glucan Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Beta Glucan Market
7.1. Soluble7.2. Insoluble
8.1. Food & Beverage8.2. Cosmetics & Personal Care8.3. Pharmaceuticals8.4. Animal Feed8.5. Other Applications
9.1. Cereal9.2. Mushroom9.3. Yeast9.4. Seaweed
10.1. Global Beta Glucan Market Size and Market Share
11.1. Asia-Pacific
11.1.1. Australia11.1.2. China11.1.3. India11.1.4. Japan11.1.5. South Korea11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France11.2.2. Germany11.2.3. Italy11.2.4. Spain11.2.5. United Kingdom11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia11.3.2. United Arab Emirates11.3.3. Qatar11.3.4. South Africa11.3.5. Egypt11.3.6. Morocco11.3.7. Nigeria11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada11.4.2. Mexico11.4.3. United States
11.5. Latin America
11.5.1. Argentina11.5.2. Brazil11.5.3. Rest of Latin America
12.1. Biotec Pharmacon ASA
12.1.1. Company details12.1.2. Financial outlook12.1.3. Product summary12.1.4. Recent developments
12.2. Biothera Pharmaceuticals
12.2.1. Company details12.2.2. Financial outlook12.2.3. Product summary12.2.4. Recent developments
12.3. Cargill Incorporated
12.3.1. Company details12.3.2. Financial outlook12.3.3. Product summary12.3.4. Recent developments
12.4. Ceapro Inc.
12.4.1. Company details12.4.2. Financial outlook12.4.3. Product summary12.4.4. Recent developments
12.5. DSM NV
12.5.1. Company details12.5.2. Financial outlook12.5.3. Product summary12.5.4. Recent developments
12.6. Frutarom
12.6.1. Company details12.6.2. Financial outlook12.6.3. Product summary12.6.4. Recent developments
12.7. Garuda International, Inc.
12.7.1. Company details12.7.2. Financial outlook12.7.3. Product summary12.7.4. Recent developments
12.8. GlycaNova AS
12.8.1. Company details12.8.2. Financial outlook12.8.3. Product summary12.8.4. Recent developments
12.9. Groupe Soufflet SA (AIT Ingredients)
12.9.1. Company details12.9.2. Financial outlook12.9.3. Product summary12.9.4. Recent developments
12.10. Immunomedics
12.10.1. Company details12.10.2. Financial outlook12.10.3. Product summary12.10.4. Recent developments
12.11. Lesaffre Human Care
12.11.1. Company details12.11.2. Financial outlook12.11.3. Product summary12.11.4. Recent developments
12.12. Millipore Sigma
12.12.1. Company details12.12.2. Financial outlook12.12.3. Product summary12.12.4. Recent developments
12.13. Super Beta Glucan Inc.
12.13.1. Company details12.13.2. Financial outlook12.13.3. Product summary12.13.4. Recent developments
12.14. Tate & Lyle Plc (Tate & Lyle Oat Ingredients)
12.14.1. Company details12.14.2. Financial outlook12.14.3. Product summary12.14.4. Recent developments
12.15. Zilor Inc (Biorigin)
12.15.1. Company details12.15.2. Financial outlook12.15.3. Product summary12.15.4. Recent developments
12.16. Others
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.



Frequently Asked Questions About This Report
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment



















